Literature DB >> 25293362

Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.

Chingching Foocharoen1, Prangsuporn Suwannachat1, Sittichai Netwijitpan1, Ajanee Mahakkanukrauh1, Siraphop Suwannaroj1, Ratanavadee Nanagara1.   

Abstract

BACKGROUND: Anti-topoisomerase I antibody (ATA) carries an increased risk of systemic sclerosis (SSc) internal organ involvement. There have been no published comparisons of the clinical characteristics of patients positive and negative for ATA in Thailand, where the positive rate for ATA is higher than among Caucasians.
OBJECTIVE: To define the clinical differences between SSc, positive versus negative, for ATA.
METHODS: A retrospective cohort study was performed among SSc patients over 18 at Srinagarind Hospital, Khon Kaen University, Thailand, during January 2006-December 2013. SSc-overlap syndrome was excluded.
RESULTS: Two hundred and ninety-four SSc patients were included (female : male 2.5 : 1). The majority (68.6%) were the diffuse cutaneous SSc subset (dcSSc). ATA was positive in 252 patients (85.7%), among whom 71.7% had dcSSc and 28.2% limited cutaneous SSc (lcSSc). Using a multivariate analysis, hand deformity had a significantly positive association with ATA (odds ratio [OR] 7.01; 95% CI 1.02-48.69), whereas being anti-centromere (ACA) positive had a negative association (OR 0.17; 95% CI 0.03-0.92). After doing a subgroup analysis of the SSc subset, the median duration of disease at time of pulmonary fibrosis detection among ATA positive dcSSc was significantly shorter than the ATA negative group (1.05 vs. 6.77 years, P = 0.01). Raynaud's phenomenon (RP) at onset was significantly more frequent in lcSSc sufferers who were ATA negative than those who were ATA positive (90.5% vs. 56.9%, P = 0.005).
CONCLUSIONS: A high prevalence of ATA positivity was found among Thai SSc patients and this was associated with a high frequency of hand deformity, ACA negativity, a short duration of pulmonary fibrosis in dcSSc and a lower frequency of RP in lcSSc.
© 2014 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  anti-Scl70; anti-topoisomerase I; autoimmune disease; scleroderma; systemic sclerosis

Mesh:

Substances:

Year:  2014        PMID: 25293362     DOI: 10.1111/1756-185X.12492

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  7 in total

1.  Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease?

Authors:  Ramya Janardana; Aswin M Nair; Ajit K Surin; John Anthony Jude Prakash; Mahasampath Gowri; Debashish Danda
Journal:  Clin Rheumatol       Date:  2019-07-15       Impact factor: 2.980

2.  Comparison of clinical presentation and incidence of cardiopulmonary complications between male and female Thai patients with early systemic sclerosis: inception cohort study.

Authors:  Suparaporn Wangkaew; Surachet Tungteerabunditkul; Narawudt Prasertwittayakij; Juntima Euathrongchit
Journal:  Clin Rheumatol       Date:  2019-04-19       Impact factor: 2.980

3.  Comparison of the clinical phenotype of systemic sclerosis patients in Iran and France in two university centers.

Authors:  Yannick Allanore; Farhad Gharibdoost; Ahmad Reza Jamshidi; Ali Javinani; Jérôme Avouac; Elnaz Rastkar; Sadid Hooshmandi; Hoda Kavosi
Journal:  J Scleroderma Relat Disord       Date:  2018-11-20

4.  Clinical Manifestation and Incidence of Cardiopulmonary Complications in Early Systemic Sclerosis Patients with Different Antibody Profiles.

Authors:  Suparaporn Wangkaew; Narawudt Prasertwittayakij; Juntima Euathrongchit
Journal:  J Clin Med Res       Date:  2019-06-11

Review 5.  Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.

Authors:  Changyi Yang; Shunli Tang; Dingxian Zhu; Yingguo Ding; Jianjun Qiao
Journal:  Front Med (Lausanne)       Date:  2020-11-19

6.  The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients.

Authors:  Yathao Paolee; Chingching Foocharoen; Suranut Charoensri; Mayfong Mayxay; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Ratanavadee Nanagara
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

7.  Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity.

Authors:  Maurizio Cutolo; Stefano Soldano; Emanuele Gotelli; Paola Montagna; Samuele Tardito; Sabrina Paolino; Carmen Pizzorni; Alberto Sulli; Vanessa Smith
Journal:  Arthritis Res Ther       Date:  2021-08-03       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.